Document is current
Any future updates will be listed below
-
Authors
Steinacker, Marie
Kheifetz, Yuri
Scholz, Markus
-
Funding
Funding for this research was provided by:
BMBF, Sächsisches Staatsministerium für Wissenschaft, Kultur und Tourismus (SCADS24B, SCADS24B)
Bundesministerium für Bildung und Forschung (031L0261, 031L0261)
Universität Leipzig
- License Information
-
More Information
Article History
Received: 6 August 2024
Accepted: 3 October 2024
First Online: 14 October 2024
Declarations
:
: Markus Scholz received funding from Pfizer Inc. and has an ongoing cooperation with Owkin for projects not related to this research.
: Data were obtained from studies of the German High-Grade Non-Hodgkin’s Lymphoma Study Group and were collected in the framework of the NHL-B study (Pfreundschuh , ).
: All patients had given informed consent and studies were approved by responsible ethics committees and were carried out in accordance with the principles of good clinical practice and the declaration of Helsinki. Details on ethics committees and reference numbers can be found in the respective publications of the studies used (Pfreundschuh , ).
: Not applicable
